CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations
Cell therapy is one of the newest therapeutic approaches for treating tissue destruction diseases and replacing damaged parts in defective tissues. Among different cells, mesenchymal stem cells (MSCs) have received a lot of attention due to their advantages and desirable properties. Also, MSCs-deriv...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Biomedicine & Pharmacotherapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222013324 |
| _version_ | 1811308621466697728 |
|---|---|
| author | Ali Hazrati Kosar Malekpour Sara Soudi Seyed Mahmoud Hashemi |
| author_facet | Ali Hazrati Kosar Malekpour Sara Soudi Seyed Mahmoud Hashemi |
| author_sort | Ali Hazrati |
| collection | DOAJ |
| description | Cell therapy is one of the newest therapeutic approaches for treating tissue destruction diseases and replacing damaged parts in defective tissues. Among different cells, mesenchymal stem cells (MSCs) have received a lot of attention due to their advantages and desirable properties. Also, MSCs-derived secretome, which includes various growth factors, cytokines, and extracellular vesicles (EVs), is used in the treatment of different types of diseases. However, the application of MSCs in an intact form brings their functionality with limitations. For this reason, different methods are recommended to increase their efficiency and the extracellular vesicles derived from them. One of these methods is gene editing of these cells. Among the different techniques for MSCs gene editing, CRISPR/Cas9 can increase the therapeutic potential of MSCs in a targeted manner due to its advantages. In order to achieve the desired result, various genes have been manipulated in MSCs, including genes involved in stemness, aging, migration, proliferation, survival, and inflammatory responses. Engineering MSCs with this method affects the cells' characteristics, changes their cytokine and different growth factors secretions, and increases their therapeutic efficiency. |
| first_indexed | 2024-04-13T09:26:31Z |
| format | Article |
| id | doaj.art-43a6383732ef40c0bea98bb21663c479 |
| institution | Directory Open Access Journal |
| issn | 0753-3322 |
| language | English |
| last_indexed | 2024-04-13T09:26:31Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Biomedicine & Pharmacotherapy |
| spelling | doaj.art-43a6383732ef40c0bea98bb21663c4792022-12-22T02:52:25ZengElsevierBiomedicine & Pharmacotherapy0753-33222022-12-01156113943CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitationsAli Hazrati0Kosar Malekpour1Sara Soudi2Seyed Mahmoud Hashemi3Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, IranDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, IranDepartment of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran; Corresponding author.Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Corresponding author at: Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Cell therapy is one of the newest therapeutic approaches for treating tissue destruction diseases and replacing damaged parts in defective tissues. Among different cells, mesenchymal stem cells (MSCs) have received a lot of attention due to their advantages and desirable properties. Also, MSCs-derived secretome, which includes various growth factors, cytokines, and extracellular vesicles (EVs), is used in the treatment of different types of diseases. However, the application of MSCs in an intact form brings their functionality with limitations. For this reason, different methods are recommended to increase their efficiency and the extracellular vesicles derived from them. One of these methods is gene editing of these cells. Among the different techniques for MSCs gene editing, CRISPR/Cas9 can increase the therapeutic potential of MSCs in a targeted manner due to its advantages. In order to achieve the desired result, various genes have been manipulated in MSCs, including genes involved in stemness, aging, migration, proliferation, survival, and inflammatory responses. Engineering MSCs with this method affects the cells' characteristics, changes their cytokine and different growth factors secretions, and increases their therapeutic efficiency.http://www.sciencedirect.com/science/article/pii/S0753332222013324Cell therapyMSCsExtracellular vesiclesCytokinesCrispr/Cas9Regenerative medicine |
| spellingShingle | Ali Hazrati Kosar Malekpour Sara Soudi Seyed Mahmoud Hashemi CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations Biomedicine & Pharmacotherapy Cell therapy MSCs Extracellular vesicles Cytokines Crispr/Cas9 Regenerative medicine |
| title | CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations |
| title_full | CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations |
| title_fullStr | CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations |
| title_full_unstemmed | CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations |
| title_short | CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations |
| title_sort | crispr cas9 engineered mesenchymal stromal stem cells and their extracellular vesicles a new approach to overcoming cell therapy limitations |
| topic | Cell therapy MSCs Extracellular vesicles Cytokines Crispr/Cas9 Regenerative medicine |
| url | http://www.sciencedirect.com/science/article/pii/S0753332222013324 |
| work_keys_str_mv | AT alihazrati crisprcas9engineeredmesenchymalstromalstemcellsandtheirextracellularvesiclesanewapproachtoovercomingcelltherapylimitations AT kosarmalekpour crisprcas9engineeredmesenchymalstromalstemcellsandtheirextracellularvesiclesanewapproachtoovercomingcelltherapylimitations AT sarasoudi crisprcas9engineeredmesenchymalstromalstemcellsandtheirextracellularvesiclesanewapproachtoovercomingcelltherapylimitations AT seyedmahmoudhashemi crisprcas9engineeredmesenchymalstromalstemcellsandtheirextracellularvesiclesanewapproachtoovercomingcelltherapylimitations |